X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-first-quarter-2024-financial-results-on-may-8-2024-302132199.html
https://www.reuters.com/legal/us-supreme-court-rejects-vanda-pharmaceuticals-case-over-sleep-drug-patents-2024-04-22/
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-adopts-limited-duration-stockholder-rights-plan-302119627.html
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-confirms-rejection-of-unsolicited-takeover-proposals-from-future-pak-302119534.html
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-fanapt-iloperidone-receives-us-fda-approval-for-the-acute-treatment-of-bipolar-i-disorder-302106405.html
https://endpts.com/fda-denies-hearing-to-vanda-on-jet-lag-indication-for-sleep-disorder-drug/
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-reports-fourth-quarter-and-full-year-2023-financial-results-302056697.html
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-fda-update-for-supplemental-nda-for-hetlioz-in-the-treatment-of-insomnia-302053260.html
https://endpts.com/vanda-takes-issue-with-fdas-relay-of-deficiencies-for-new-hetlioz-indication/
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-receives-fda-approval-to-proceed-with-investigational-new-drug-vtr-297-a-topical-antifungal-candidate-for-the-treatment-of-onychomycosis-302049362.html
Market Place
Share 
